Acadia Healthcare (NASDAQ:ACHC – Free Report) had its price target reduced by Mizuho from $37.00 to $32.00 in a research note issued to investors on Wednesday,Benzinga reports. They currently have a neutral rating on the stock.
A number of other research analysts have also issued reports on ACHC. Bank of America reduced their target price on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating for the company in a research note on Friday, February 28th. KeyCorp reduced their price objective on Acadia Healthcare from $65.00 to $55.00 and set an “overweight” rating for the company in a research report on Wednesday. Barclays cut Acadia Healthcare from an “overweight” rating to an “equal weight” rating and lowered their target price for the company from $43.00 to $35.00 in a research report on Friday, February 28th. Royal Bank of Canada reduced their price target on Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating for the company in a research report on Monday, March 3rd. Finally, Guggenheim started coverage on Acadia Healthcare in a report on Wednesday, April 9th. They set a “buy” rating and a $36.00 price target on the stock. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $47.94.
Get Our Latest Stock Analysis on Acadia Healthcare
Acadia Healthcare Trading Up 2.0%
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last issued its earnings results on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.05. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm had revenue of $770.51 million for the quarter, compared to analyst estimates of $769.90 million. During the same period last year, the company earned $0.84 earnings per share. The firm’s revenue for the quarter was up .3% on a year-over-year basis. Equities research analysts expect that Acadia Healthcare will post 3.38 EPS for the current year.
Institutional Investors Weigh In On Acadia Healthcare
Several hedge funds and other institutional investors have recently bought and sold shares of the business. FMR LLC grew its stake in shares of Acadia Healthcare by 257.9% in the 4th quarter. FMR LLC now owns 6,230,631 shares of the company’s stock worth $247,045,000 after purchasing an additional 4,489,681 shares during the last quarter. Citigroup Inc. grew its position in Acadia Healthcare by 5,144.2% in the first quarter. Citigroup Inc. now owns 2,376,209 shares of the company’s stock worth $72,047,000 after buying an additional 2,330,898 shares during the last quarter. Hawk Ridge Capital Management LP grew its position in Acadia Healthcare by 437.5% in the first quarter. Hawk Ridge Capital Management LP now owns 2,473,226 shares of the company’s stock worth $74,988,000 after buying an additional 2,013,126 shares during the last quarter. Madison Avenue Partners LP bought a new position in shares of Acadia Healthcare in the fourth quarter valued at $76,339,000. Finally, Abrams Bison Investments LLC acquired a new stake in shares of Acadia Healthcare during the 1st quarter valued at $55,182,000.
About Acadia Healthcare
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Stories
- Five stocks we like better than Acadia Healthcare
- What Do S&P 500 Stocks Tell Investors About the Market?
- Meta’s 5 Key Pillars for AI Growth—Zuckerberg’s Bold Vision
- Earnings Per Share Calculator: How to Calculate EPS
- Retail Investors Are Betting Big on Rocket Lab—Should You Too?
- How to Invest in the FAANG Stocks
- GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.